This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Weiming, Z. Articles by Jieshou, L. Search for Related Content PubMed PubMed Citation Articles by Weiming, Z. Articles by Jieshou, L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diets Social Bookmarking                         What's this?

Effect of Recombinant Human Growth Hormone and Enteral Nutrition on Short Bowel Syndrome

From the Department of General Surgery, Jinling Hospital, Nanjing, Jiangsu, China

Correspondence: Zhu Weiming, PhD, Department of General Surgery, Jinling Hospital, Nanjing 210002, Jiangsu, China. Electronic mail may be sent to Juwiming{at}yahoo.com.cn.

Background: Studies showed that bowel rehabilitation therapy, including recombinant human growth hormone (rhGH), nutrition support, glutamine, and dietary fiber, promotes intestinal adaptation in patients with short bowel syndrome. The aim of the current study was to determine if enteral nutrition and rhGH are effective in weaning short bowel patients off total parenteral nutrition (TPN). Methods: Thirty-seven patients with short bowel syndrome received bowel rehabilitation therapy for 4 weeks. Thirty-four patients were treated within 2 years after short bowel syndrome. Treatment included nutrition support from enteral nutrition 500 to 1500 kcal/d, oral glutamine 0.6 g/kg/d, plus a high-carbohydrate and low-fat diet. Once patients were in positive nitrogen balance, rhGH 0.05 mg/kg/d was administered for 3 weeks. Results: All patients completed the treatment; there were no deaths caused by malnutrition. Intestinal absorptive capacity and plasma levels of proteins were significantly improved after treatment (p < .05). Of the 23 patients who have been followed for >2 years after bowel rehabilitation therapy, 21 patients (57%) weaned off parenteral nutrition, among which 18 (49%) patients lived on a high-carbohydrate and low-fat diet supplemented with enteral nutrition, and 3 patients were free of enteral nutrition and relied on high-carbohydrate and low-fat diet alone. The minimal intestinal length for these patients was 15 cm with ileocecal valve and intact colon in adults. Conclusions: Providing patients with enteral nutrition, glutamine, dietary fiber, and rhGH during bowel rehabilitation therapy allows weaning from TPN in a significant number of patients.

Journal of Parenteral and Enteral Nutrition, Vol. 28, No. 6, 377-381 (2004)
DOI: 10.1177/0148607104028006377


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Q. Huang, N. Li, W. Zhu, Q. Li, and J. Li Glutamine Transporter ASCT2 Was Down-Regulated in Ischemic Injured Human Intestinal Epithelial Cells and Reversed by Epidermal Growth Factor JPEN J Parenter Enteral Nutr, March 1, 2007; 31(2): 86 - 93. [Abstract] [Full Text] [PDF]

				D. Axelrod, K. Kazmerski, and K. Iyer Pediatric Enteral Nutrition JPEN J Parenter Enteral Nutr, January 1, 2006; 30(1_suppl): S21 - S26. [Abstract] [Full Text] [PDF]

				N. R. Parekh and E. Steiger Criteria for the Use of Recombinant Human Growth Hormone in Short Bowel Syndrome Nutr Clin Pract, October 1, 2005; 20(5): 503 - 508. [Abstract] [Full Text] [PDF]